Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer

Abroad (travel likely)RecruitingPHASE4

Conditions

Breast Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Cross Cancer Institute, Edmonton, Alberta, Canada

  • Waterloo Regional Health Network, Kitchener, Ontario, Canada

  • London Health Sciences Centre, London, Ontario, Canada

  • Oak Valley Health, Markham, Ontario, Canada

  • The Ottawa Hospital, Ottawa, Ontario, Canada

  • Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada

  • Allan Blair Cancer Centre, Regina, Saskatchewan, Canada

  • Saskatoon Cancer Centre, Saskatoon, Saskatchewan, Canada

Study leads
  • Marie-France Savard, MD

    Principal Investigator

    Ottawa Hospital Research Institute